Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Sulfurous Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfurous Acid SCHEMBL28977015 | 0.95 | CA1 (0.46) | CA1CA2 | |
| Sulfurous Acid SCHEMBL11239933 | 0.95 | CA1 (0.46) | CA1CA2 | |
| Sulfurous Acid SCHEMBL28242812 | 0.91 | CA1 (0.42) | CA1CA2 | |
| Sulfurous Acid SCHEMBL16034921 | 0.91 | CA1 (0.42) | CA1CA2 | |
| Sulfurous Acid SCHEMBL65585 | 0.91 | — | — | |
| Sulfurous Acid SCHEMBL4280222 | 0.91 | CA1 (0.50) | CA1CA2 | |
| Sulfurous Acid SCHEMBL250500 | 0.91 | — | — | |
| Sulfurous Acid SCHEMBL8904099 | 0.86 | — | — | |
| Sulfurous Acid SCHEMBL8682948 | 0.86 | — | — | |
| Sulfurous Acid SCHEMBL22817896 | 0.86 | CA1 (0.46) | CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118785909-A | Use of 5-amino-2, 3-dihydro-1, 4-phthalazinediones for the treatment of congenital muscular dystrophy | 麦翠奥制药公司 | 2024-10-15 | — | — | CN | disclosed |